Skip to content

ART-DIAL: Art Therapy as an Innovative Approach to Stress Reduction During Hemodialysis

ART-DIAL: Art Therapy as an Innovative Approach to Stress Reduction During Hemodialysis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00038276
Enrollment
20
Registered
2025-10-28
Start date
2025-11-05
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N18.5 Z99.2

Interventions

Group 1: Participating patients receive weekly 45-60 minute art therapy sessions at their dialysis bedside over a 12-week period.

Sponsors

Robert Bosch Krankenhaus
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Chronic hemodialysis requirement for at least 3 months Regular hemodialysis treatment (at least 2×/week) at Robert Bosch Hospital Stuttgart Sufficient German language skills to participate in interviews and complete questionnaires Written informed consent after comprehensive patient information

Exclusion criteria

Exclusion criteria: Severe cognitive impairment that makes study participation impossible Severe visual impairment that makes performing visual artistic activities impossible Acute severe psychiatric disorders (active psychosis, severe mania) Lack of capacity to consent Expected kidney transplantation or change of dialysis center within the next 3 months Participation in another interventional study with psychological well-being or quality of life as primary endpoint

Design outcomes

Primary

MeasureTime frame
Change in disease-specific quality of life measured with the Kidney Disease Quality of Life Instrument (KDQOL) German version Assessment timepoints: T0 (Baseline): 1-2 weeks before intervention start T12 (End of intervention): After 12 weeks (directly after last art therapy session)

Secondary

MeasureTime frame
1. Psychological Parameters: Stress: Perceived Stress Scale (PSS-10) - Assessment at baseline (T0) and week 12 (T12) Anxiety: Hospital Anxiety and Depression Scale - Anxiety subscale (HADS-A) - Assessment at T0 and T12 Subjective well-being during dialysis: Visual Analogue Scale (VAS, 0-10) - Assessment at T0 and weekly after each art therapy session (T1-T12) 2. Clinical Parameters: Interdialytic weight gain: Difference between dry weight and pre-dialysis weight (kg) - Retrospective data 4 weeks before intervention and continuous documentation during 12-week intervention period Blood pressure during dialysis: Mean systolic blood pressure values - Retrospective data before intervention and prospective documentation during each session (T1-T12) Premature therapy discontinuation: Number and reasons - Continuous documentation throughout intervention period (weeks 1-12) Cortisol levels: Saliva samples collected before and after art therapy sessions at weeks 4, 8, and 12, with baseline measurement at T0 3. Therapeutic Adherence: Participation rate: Number of attended sessions divided by number of planned sessions - Continuous documentation, evaluated at T12 Engagement: Therapist rating of patient engagement using a 5-point Likert scale - Assessment after each session (T1-T12) 4. Qualitative Outcomes: Patient perspective: Semi-structured interviews exploring subjective experience of the intervention, perceived changes in coping with dialysis treatment, impact on daily life and disease management, and feedback for improvement - Assessment at T12 Staff perspective: Semi-structured interviews examining observed changes in participating patients, impact on workflow and care quality, acceptance and integration of intervention into clinical routine, and recommendations for future implementation - Assessment at T12 Art therapy process analysis: Documentation of artistic expression development, thematic content of artworks, therapeutic relationship dynamics,

Countries

Germany

Contacts

Public ContactSeverin Schricker

Robert Bosch Krankenhaus

severin.schricker@rbk.de+4971181013496

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026